Trial Profile
Effects of second generation drug-eluting stent implantation on target lesion revascularization
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Mar 2016
Price :
$35
*
At a glance
- Drugs Zotarolimus (Primary) ; Everolimus
- Indications Coronary artery restenosis
- Focus Adverse reactions
- 12 Mar 2016 New trial record